Pfizer
Daniela Orgiana is an experienced professional in business analytics and marketing within the pharmaceutical and animal health sectors. Currently serving as the Business Analytics & Insights Director Country Lead for Italy at Pfizer since May 2016, Daniela has held various key roles within the company, including Global Sr. Business Intelligence Manager and Business Intelligence Manager for Immunology & Inflammation across EU, Japan, and Developed Asia. Prior to Pfizer, Daniela worked at Zoetis Inc. as Marketing Manager for Vaccines in livestock and at Pfizer Italia in multiple marketing and sales capacities. Daniela began a career in consulting at Booz Allen Hamilton as a Strategic Consultant in Communication Media Technology. Educational qualifications include a Management Engineering degree from Politecnico di Torino and multiple marketing programs from SDA Bocconi.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.